| 1 | OSMR, SHC1
|
| Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
|
| Persson E, Souza PPC, Floriano-Marcelino T, Conaway HH, Henning P, Lerner UH.
|
| Front Immunol 10:1164. doi: 10.3389/fimmu.2019.01164. eCollection 2019.
2019
|
| 2 | CXCL12, OSMR
|
| Oncostatin M Mediates Adipocyte Expression and Secretion of Stromal-Derived Factor 1.
|
| Hang H, Bailey JL, Elks CM.
|
| Biology (Basel) 8(1). pii: E19. doi: 10.3390/biology8010019.
2019
|
| 3 | OSMR
|
| The role of oncostatin M receptor gene polymorphisms in bladder cancer.
|
| Deng S, He SY, Zhao P, Zhang P.
|
| World J Surg Oncol 17(1):30. doi: 10.1186/s12957-018-1555-7.
2019
|
| 4 | GFAP, OSMR, SMARCA4, STAT3
|
| Gfap and Osmr regulation by BRG1 and STAT3 via interchromosomal gene clustering in astrocytes.
|
| Ito K, Noguchi A, Uosaki Y, Taga T, Arakawa H, Takizawa T.
|
| Mol Biol Cell 29(2):209-219. doi: 10.1091/mbc.E17-05-0271. Epub 2017 Nov 15.
2018
|
| 5 | OSMR
|
| OSMR gene effect on the pathogenesis of chronic autoimmune Urticaria via the JAK/STAT3 pathway.
|
| Luo XY, Liu Q, Yang H, Tan Q, Gan LQ, Ren FL, Wang H.
|
| Mol Med 24(1):28. doi: 10.1186/s10020-018-0025-6.
2018
|
| 6 | OSM, OSMR
|
| Oncostatin M Confers Neuroprotection against Ischemic Stroke.
|
| Guo S, Li ZZ, Gong J, Xiang M, Zhang P, Zhao GN, Li M, Zheng A, Zhu X, Lei H, Minoru T, Li H.
|
| J Neurosci 35(34):12047-62. doi: 10.1523/JNEUROSCI.1800-15.2015.
2015
|
| 7 | IL31, OSM, OSMR
|
| Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology.
|
| Hermanns HM.
|
| Cytokine Growth Factor Rev ytokine Growth Factor Rev. 2015 Jul 3. pii: S1359-6101(15)00054-4. doi: 10.1016/j.cytogfr.2015.07.006. [Epub ahead of print] Rev 2015
|
| 8 | FPLCA, OSMR
|
| A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
|
| Saeedi M, Ebrahim-Habibi A, Haghighi A, Zarrabi F, Amoli MM, Robati RM.
|
| Biomed Res Int 2014:653724. doi: 10.1155/2014/653724. Epub 2014 Jun 26.
2014
|
| 9 | OSMR
|
| Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma.
|
| Caffarel MM, Chattopadhyay A, Araujo AM, Bauer J, Scarpini CG, Coleman N.
|
| J Pathol 231(2):168-79. doi: 10.1002/path.4222.
2013
|
| 10 | LIFR, OSMR
|
| A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor.
|
| Chollangi S, Mather T, Rodgers KK, Ash JD.
|
| J Biol Chem 287(39):32848-59. Epub 2012 Jul 24.
2012
|
| 11 | OSMR
|
| Methylation of OSMR gene is frequently observed in non-invasive colorectal cancer.
|
| Hibi K, Goto T, Sakuraba K, Shirahata A, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y.
|
| Anticancer Res 31(4):1293-5.
2011
|
| 12 | FPLCA, OSMR
|
| The molecular skin pathology of familial primary localized cutaneous amyloidosis.
|
| Tanaka A, Lai-Cheong JE, van den Akker PC, Nagy N, Millington G, Diercks GF, van Voorst Vader PC, Clements SE, Almaani N, Techanukul T, Hide M, South AP, McGrath JA.
|
| Exp Dermatol 19(5):416-23. doi: 10.1111/j.1600-0625.2010.01083.x.
2010
|
| 13 | FPLCA, OSMR
|
| Oncostatin M Receptor-beta Mutations Underlie Familial Primary Localized Cutaneous Amyloidosis.
|
| Arita K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J, Clements S, Odashiro M, Odashiro DN, Hans-Neto G, Hans NR, Holder MV, Bhogal BS, Hartshorne ST, Akiyama M, Shimizu H, McGrath JA.
|
| Am J Hum Genet 82(1):73-80. 2008
|
| 14 | BASP1, BRD9, DROSHA, NDUFS6, NNT, OSMR, PAIP1, PAPD7, RAD1, SDHA, SKP2, TARS
|
| Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha.
|
| Scotto L, Narayan G, Nandula SV, Subramaniyam S, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Schneider A, Arias-Pulido H, Murty VV.
|
| Mol Cancer 7:58. 2008
|
| 15 | OSMR, OSM
|
| Molecular and functional characterization of a soluble form of oncostatin M/interleukin-31 shared receptor.
|
| Diveu C, Venereau E, Froger J, Ravon E, Grimaud L, Rousseau F, Chevalier S, Gascan H.
|
| J Biol Chem 281(48):36673-82. Epub 2006 Oct 6. 2006
|
| 16 | ENC1, LIFRAS, LIFR, HEXB, GFM2, OSMR
|
| Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC-1AS and identification of ENC-1 overexpression in hairy cell leukemia.
|
| Hammarsund M, Lerner M, Zhu C, Merup M, Jansson M, Gahrton G, Kluin-Nelemans H, Einhorn S, Grander D, Sangfelt O, Corcoran M.
|
| Hum Mol Genet 13(23):2925-36. Epub 2004 Sep 30. 2004
|
| 17 | OSMR
|
| Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
|
| Savarese TM, Campbell CL, McQuain C, Mitchell K, Guardiani R, Quesenberry PJ, Nelson BE.
|
| Cytokine 17(6):324-34. 2002
|
| 18 | OSMR
|
| Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression.
|
| Radtke S, Hermanns HM, Haan C, Schmitz-Van De Leur H, Gascan H, Heinrich PC, Behrmann I.
|
| J Biol Chem 277(13):11297-305. Epub 2002 Jan 10. 2002
|
| 19 | OSMR
|
| Regulation of the type II oncostatin M receptor expression in lung-derived epithelial cells.
|
| Cichy J, Rose-John S, Pure E.
|
| FEBS Lett 429(3):412-6. 1998
|
| 20 | OSMR
|
| Signaling of type II oncostatin M receptor.
|
| Auguste P, Guillet C, Fourcin M, Olivier C, Veziers J, Pouplard-BarthelaixA, Gascan H.
|
| J Biol Chem 272(25):15760-4. 1997
|
| 21 | OSMR
|
| Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
|
| Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D.
|
| J Biol Chem 271(51):32635-43. 1996
|